Loading company…
Medisby develops AI-based robotic devices that replicate therapist-programmed joint mobilization treatments.
Founded in 2024 and based in Seoul, South Korea, Medisby develops robotic medical devices for joint mobilization therapy. Its robots learn and replicate movements programmed by medical professionals for upper and lower limb therapies, reducing therapist involvement from 30 to 5 minutes per session. The company plans to develop an autonomous AI therapy platform and expand into the U.S., Japan, China and Uzbekistan. In April 2025, it raised Seed funding from Digital Healthcare Partners.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in